Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > New Press Release - Sirona Biochem Announces Close of Private Placement

<< Previous

Bullboard Posts

Next >>

Comment by tylerreddickon Apr 04, 2024 11:03pm

121 Views

Post# 35971881

RE:New Press Release - Sirona Biochem Announces Close of Private Placement

Well, at least they didn't reprice it down, but the falling share price must have scared most potential investors off. Of note, Howie didn't participate, even a little. I guess he only likes the sweetheart deals?

But we aren't desperate for money right now, so better to have a smaller placement than reprice it and give more shares away for nothing.

And who knows, maybe Sirona Labs has that "partner" lined up? Wouldn't that be a nice surprise, and a HUGE boost to the share price...........a guy can dream, can't he? :o)

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals